中国医药公司江苏 恒瑞医药 (Jiangsu Hengrui Pharmaceuticals, 1276.HK)的股票在香港挂牌交易首日飙升，突显出随着更多公司寻求利用香港的资本市场，IPO活动也在大增。 恒瑞医药的股票在周五早盘跳涨31%至57.65港元，而基准恒生指数小幅上涨0.6%。

This year’s fair not only showcases China’s cultural soft power but also highlights its commitment to fostering global cultural trade and technological collaboration, with the first-ever "Chinese ...

陈家齐 解释，港投公司进行投资，除了争取中长期回报，亦希望不同公司落户香港。这些公司在取得港投公司的投资后，在寻找其他资金、进入海外市场等成长速度快于预期。陈家齐又称，港投公司每投资 1 元，现时已能带动超过 4 ...

尽管这两个超级大国之间的较量已造成了附带金融损失，但宁德时代在香港二次上市前仍 筹集 ...

Guests attend the listing ceremony of Chinese electric vehicle (EV) battery maker Contemporary Amperex Technology (CATL) at ...

Debutto in volata per Catl a Hong Kong. Nel giorno dello sbarco in Borsa, i titoli del più grande produttore mondiale di ...